Mixed Periampullary Adenocarcinoma and Somatostatinoma with Small Bowel Gastrointestinal Stromal Tumour in Neurofibromatosis Type 1
Abstract
Context Gastrointestinal (GI) involvement is present in about one quarter of cases of neurofibromatosis type 1 (NF1). Adenocarcinomas have been reported in several organs. Gastrointestinal stromal tumors are the most common GI lesion seen in NFI. GISTs in combination with ampullary neuroendocrine tumors in NF-1 have been reported rarely. Case report We present the case of a 44-year-old man who presented with a history of obstructive jaundice and weight loss. Investigations revealed a pancreatic tumor associated with a common bile duct (CBD) stricture. At operation, an ampullary adenocarcinoma that infiltrated into the head of pancreas with an adjacent somatostatinoma was found. In addition, a small bowel GIST was present. Conclusions Mixed periampullary adenocarcinoma and somatostatinoma in a patient with NF1 has only been previously reported once. The current case highlights the spectrum of associated tumor types which can be seen in association with NF1. Patients with NF1 who present with jaundice and weight loss should be investigated in the usual manner with increased suspicion for duodenal and ampullary tumors.
Image: MRCP demonstrating significant intra-hepatic biliary duct dilatation.
Downloads
References
Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med 1981; 305: 1617-1627. [PMID: 6796886]
Korf BR. Malignancy in neurofibromatosis type 1. Oncologist 2000; 5: 477-485. [PMID: 11110599]
Davis GB, Berk RN. Intestinal neurofibromas in von Recklinghausen's disease. Am J Gastroenterol 1973; 60: 410-414. [PMID: 4202254]
Costi R, Caruana P, Sarli L, Violi V, Roncoroni L, et al. Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review. Mod Pathol 2001; 14: 1169-1174. [PMID: 11706080]
Behranwala KA, Spalding D, Wotherspoon A, Fisher C, Thompson JN. Small bowel gastrointestinal stromal tumours and ampullary cancer in Type 1 neurofibromatosis. World J Surg Oncol 2004; 2: 1.[PMID: 14711379]
Desigan G, Dunn GD, Halter S. Adenocarcinoma of the esophagus associated with neurofibromatosis. J Tenn Med Assoc 1985; 78: 138-140. [PMID: 3920445]
Basu S, Majumdar J, Mitra R, Chowdhury JR. Primary adenocarcinoma of the stomach associated with peripheral neurofibromatosis: report of a case. Surg Today 1997; 27: 57-59. [PMID: 9035301]
Wormsley KG, Logan WF, Sorrell VF, Cole GC. Neurofibromatosis with pancreatic duct obstruction and steatorrhoea. Postgrad Med J 1967; 43: 432-435. [PMID: 4963049]
Jones TJ, Marshall TL. Neurofibromatosis and small bowel adenocarcinoma: an unrecognised association. Gut 1987; 28: 1173-1176. [PMID: 3119436]
Jenkins DH, Gill W. A case of carcinoma of the colon in association with neurofibromatosis. Br J Surg 1972; 59: 322-323. [PMID: 4623189]
Ching CK, Greer AJ. Metachronous biliary tract cancers in a patient with von Recklinghausen's disease. Am J Gastroenterol 1993; 88: 1124-1125. [PMID: 8317420]
Sprengers DP, Knockaert DC, Van Steenbergen W, Penninckx F. Primary bile duct cancer and von Recklinghausen disease. Ann Intern Med 1987; 106: 772. [PMID: 3105377]
Keller RT, Logan GM Jr. Adenocarcinoma of the pancreas associated with neurofibromatosis. Cancer 1977; 39: 1264-1266. [PMID: 410497]
Deschamps L, Dokmak S, Guedj N, Ruszniewski P, Sauvanet A, et al. Mixed endocrine somatostatinoma of the ampulla of vater associated with a neurofibromatosis type 1: a case report and review of the literature. JOP 2010; 11: 64-68. [PMID: 20065557]
Rogers A, Wang LM, Karavitaki N, Grossman AB. Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognized. QJM 2012. [PMID: 23173186]
Mao C, Shah A, Hanson DJ, Howard JM. Von Recklinghausen's disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas. J Surg Oncol 1995; 59: 67-73. [PMID: 7745981]
Jensen RT, Berna MJ, Bingham DB, Norton JA. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 2008, 113: 1807-1843. [PMC: 2574000]
Bettini R, Falconi M, Crippa S, Capelli P, Boninsegna L, et al. Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. World J Gastroenterol 2007; 13: 2761-2763. [PMID: 17569151]
Relles D, Baek J, Witkiewicz A, Yeo CJ. Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases. J Gastrointest Surg 2010; 14: 1052-1061. [PMID: 20300877]
Hirashima K, Takamori H, Hirota M, Tanaka H, Ichihara A, et al. Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: report of a case. Surg Today 2009; 39: 979-983. [PMID: 19882321]
Ozcinar B, Aksakal N, Agcaoglu O, Tukenmez M, Ozemir IA, et al. Multiple gastrointestinal stromal tumors and pheochromocytoma in a patient with von Recklinghausen's disease. Int J Surg Case Rep 2013 4: 216-218. [PMID: 23287063]
Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006; 30: 90-96. [PMID: 16330947]
Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, et al. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 2005; 29: 1170-1176. [PMID: 16096406]
Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 2004; 202: 80-85. [PMID: 14694524]
Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006; 15: 1015-1023. [PMID: 16461335]
Dominguez-Comesaña E, Tome-Espiñeiro C, Ulla-Rocha JL, Lorenzo-Lorenzo I, Lede-Fernandez A, et al. Coincidence of GIST and pancreatic endocrine neoplasm in neurofibromatosis. Asia Pac J Clin Oncol 2011; 7: 193-196. [PMID: 21884431]
Njei B, Sanchez H. Education and imaging. Gastrointestinal: neurofibromatosis type 1, duodenal somatostatinoma and gastrointestinal stromal tumors; a triad worth remembering. J Gastroenterol Hepatol 2014, 29: 663. [PMID: 24646427]
Barahona-Garrido J, Aguirre-Gutierrez R, Gutierrez-Manjarrez JI, Tellez-Avila FI, Lopez-Arce G, Fomperoza-Torres A, Criales S, et al. Association of GIST and somatostatinoma in a patient with type-1 neurofibromatosis: is there a common pathway? Am J Gastroenterol 2009; 104: 797-799. [PMID: 19223891]
Cordier R. Les cellules argentaffines dans les tumeurs intestinales. Arch Int Med Exp 1924; 1: 59.
Lewin K (1987) Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 11 Suppl 1: 71-86.
Rindi G, Arnold R, Bosman F, Capella C, Kilmstra D, Kloppel G, Komminoth P, Solcia E: Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours of the Digestive System. edn. Edited by Bosman F, Carneiro F, Hruban R, Thiese N. Lyon, France: IARC Press; 2010: 13-14.
La Rosa S1, Marando A, Sessa F, Capella C (2012) Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. Cancers (Basel) 4: 11-30.
Stephenson T, Cross S, Chetty R: Dataset for neuroendocrine tumours of the gastrointestinal tract including pancreas (3rd edition). The Royal College of Pathologists; 2012 (viewed 11th July 2014) Available from: http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/G081_DatasetGIEndocrine_Sep12.pdf
Copyright (c) 2014 Nilanjana Tewari, Katie Rollins, Nirav Gandhi, Phillip Kaye, Dileep N Lobo
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.